This is the protocol for a review and there is no abstract. The objectives are as follows:
(1) To assess the benefits and risks of cerebrolysin for treating acute ischemic stroke.
(2) To estimate the effect of cerebrolysin on survival and disability .
(3) To assess serious adverse events and adverse effects.